Akiyama F, Stevens R L, Hayashi S, Swann D A, Binette J P, Caterson B, Schmid K, Van Halbeek H, Mutsaers J H, Gerwig G J
Arch Biochem Biophys. 1987 Feb 1;252(2):574-90. doi: 10.1016/0003-9861(87)90065-8.
A large Mr chondroitin sulfate proteoglycan was extracted from the media of human aorta under dissociative conditions and purified by density-gradient centrifugation, ion-exchange chromatography, and gel filtration chromatography. Removal of a contaminating dermatan sulfate proteoglycan was accomplished by reduction, alkylation and rechromatography on the gel filtration column. After chondroitinase ABC treatment, the proteoglycan core was separated from a residual heparan sulfate proteoglycan by a third gel filtration chromatography step. As assessed by radioimmunoassay, the isolated proteoglycan core was free of link protein, but possessed epitopes that were recognized by antisera against the hyaluronic acid binding region of bovine cartilage proteoglycan as well as those that were weakly recognized by anti-keratan sulfate antisera. Following beta-elimination of the protein core, the liberated low Mr oligosaccharides were partially resolved by Sephadex G-50 chromatography, and their primary structure was determined by 500-MHz1H NMR spectroscopy in combination with compositional sugar analysis. The N-glycosidic carbohydrate chains, which were obtained as glycopeptides, were all biantennary glycans containing NeuAc and Fuc; microheterogeneity in the NeuAc----Gal linkage was detected in one of the branches. The N-glycosidic glycans have the following overall structure: (Formula: see text). The majority of the O-glycosidic carbohydrate chains bound to the protein core were found to be of the mucin type. They were obtained as glycopeptides and oligosaccharide alditols, and possessed the following structures: NeuAc alpha(2----3)Gal beta(1----3)GalNAc-ol, [NeuAc alpha(2----3)Gal beta(1----3)[NeuAc alpha(2----6)]GalNAc-ol, and NeuAc alpha-(2----3) Gal beta(1----3)[NeuAc alpha(2----3)Gal beta(1----4)GlcNAc beta(1----6)] GalNAc-ol. The remainder of the O-glycosidic carbohydrate chains bound to the isolated proteoglycan were the hexasaccharide link regions of the chondroitin sulfate chains that remained after chondroitinase ABC treatment of the native molecule. These latter glycans, which were obtained as oligosaccharide alditols, had the following structure (with GalNAc free of sulfate or containing sulfate bound at either C-4 or C-6): delta 4,5GlcUA beta(1----3)GalNAc beta(1----4)GlcUA beta(1----3)Gal beta(1----3)Gal beta(1----4)Xyl-ol.
在解离条件下从人主动脉培养基中提取一种大分子硫酸软骨素蛋白聚糖,并通过密度梯度离心、离子交换色谱和凝胶过滤色谱进行纯化。通过还原、烷基化以及在凝胶过滤柱上重新色谱分离去除污染的硫酸皮肤素蛋白聚糖。经软骨素酶ABC处理后,通过第三步凝胶过滤色谱步骤将蛋白聚糖核心与残留的硫酸乙酰肝素蛋白聚糖分离。通过放射免疫测定评估,分离出的蛋白聚糖核心不含连接蛋白,但具有可被抗牛软骨蛋白聚糖透明质酸结合区域抗血清识别的表位,以及可被抗硫酸角质素抗血清弱识别的表位。蛋白核心经β-消除后,释放的低分子量寡糖通过Sephadex G-50色谱部分分离,其一级结构通过500-MHz 1H NMR光谱结合组成糖分析确定。作为糖肽获得的N-糖苷碳水化合物链均为含有NeuAc和Fuc的双天线聚糖;在其中一个分支中检测到NeuAc→Gal连接的微不均一性。N-糖苷聚糖具有以下总体结构:(分子式:见正文)。发现与蛋白核心结合的大多数O-糖苷碳水化合物链为粘蛋白型。它们作为糖肽和寡糖糖醇获得,并具有以下结构:NeuAcα(2→3)Galβ(1→3)GalNAc-ol、[NeuAcα(2→3)Galβ(1→3)[NeuAcα(2→6)]GalNAc-ol和NeuAcα-(2→3)Galβ(1→3)[NeuAcα(2→3)Galβ(1→4)GlcNAcβ(1→6)]GalNAc-ol。与分离出的蛋白聚糖结合的其余O-糖苷碳水化合物链是天然分子经软骨素酶ABC处理后残留的硫酸软骨素链的六糖连接区域。这些后一种聚糖作为寡糖糖醇获得,具有以下结构(GalNAc无硫酸根或在C-4或C-6处结合有硫酸根):δ4,5GlcUAβ(1→3)GalNAcβ(1→4)GlcUAβ(1→3)Galβ(1→3)Galβ(1→4)Xyl-ol。